Literature DB >> 20094878

Characterization of the leishmanicidal activity of antimicrobial peptides.

Juan Román Luque-Ortega1, Luis Rivas.   

Abstract

This chapter describes the basic methodology to assay the activity of antimicrobial peptides (AMPs) on Leishmania, a human protozoan parasite. The protocols included can be methodologically divided into two major blocks. The first one addresses the basic technology for growth of the different stages of Leishmania, assessment of leishmanicidal activity, and monitoring of plasma membrane permeabilization. The second block encompasses the monitoring of bioenergetic parameters of the parasite, visualization of structural damage by transmission electron microscopy, or those methods more closely related to the involvement of intracellular AMP targets, as subcellular localization of the peptide and induction of parasite apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20094878     DOI: 10.1007/978-1-60761-594-1_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  In vitro activities of hexaazatrinaphthylenes against Leishmania spp.

Authors:  Atteneri López-Arencibia; Daniel García-Velázquez; Carmen M Martín-Navarro; Ines Sifaoui; María Reyes-Batlle; Jacob Lorenzo-Morales; Ángel Gutiérrez-Ravelo; José E Piñero
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

2.  Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo.

Authors:  Marie Crisel B Erfe; Consuelo V David; Cher Huang; Victoria Lu; Ana Claudia Maretti-Mira; Jacquelyn Haskell; Kevin W Bruhn; Michael R Yeaman; Noah Craft
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

3.  Enterocin AS-48 as Evidence for the Use of Bacteriocins as New Leishmanicidal Agents.

Authors:  María Ángeles Abengózar; Rubén Cebrián; José María Saugar; Teresa Gárate; Eva Valdivia; Manuel Martínez-Bueno; Mercedes Maqueda; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

4.  Essential Role of Enzymatic Activity in the Leishmanicidal Mechanism of the Eosinophil Cationic Protein (RNase 3).

Authors:  María Ángeles Abengózar; María Fernández-Reyes; Vivian A Salazar; Marc Torrent; Beatriz G de la Torre; David Andreu; Ester Boix; Luis Rivas
Journal:  ACS Infect Dis       Date:  2022-06-22       Impact factor: 5.578

5.  Mechanisms of action of substituted β-amino alkanols on Leishmania donovani.

Authors:  María Ángeles Abengózar; Luis A Bustos; Raquel García-Hernández; Pilar Fernández de Palencia; Ricardo Escarcena; Santiago Castanys; Esther del Olmo; Francisco Gamarro; Arturo San Feliciano; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

6.  Molecular Basis of the Leishmanicidal Activity of the Antidepressant Sertraline as a Drug Repurposing Candidate.

Authors:  Marta L Lima; María A Abengózar; Montserrat Nácher-Vázquez; María P Martínez-Alcázar; Coral Barbas; Andre G Tempone; Ángeles López-Gonzálvez; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

7.  UCP2 deficiency helps to restrict the pathogenesis of experimental cutaneous and visceral leishmaniosis in mice.

Authors:  Javier Carrión; M Angeles Abengozar; María Fernández-Reyes; Carlos Sánchez-Martín; Eduardo Rial; Gustavo Domínguez-Bernal; M Mar González-Barroso
Journal:  PLoS Negl Trop Dis       Date:  2013-02-21

8.  Investigation of the Anti-Leishmania (Leishmania) infantum Activity of Some Natural Sesquiterpene Lactones.

Authors:  Imke F Wulsten; Thais A Costa-Silva; Juliana T Mesquita; Marta L Lima; Mariana K Galuppo; Noemi N Taniwaki; Samanta E T Borborema; Fernando B Da Costa; Thomas J Schmidt; Andre G Tempone
Journal:  Molecules       Date:  2017-04-25       Impact factor: 4.411

9.  Human chemokines as antimicrobial peptides with direct parasiticidal effect on Leishmania mexicana in vitro.

Authors:  Sara K Söbirk; Matthias Mörgelin; Arne Egesten; Paul Bates; Oonagh Shannon; Mattias Collin
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

10.  Antileishmanial activity of the estrogen receptor modulator raloxifene.

Authors:  Juliana Q Reimão; Danilo C Miguel; Noemi N Taniwaki; Cristiana T Trinconi; Jenicer K U Yokoyama-Yasunaka; Silvia R B Uliana
Journal:  PLoS Negl Trop Dis       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.